{"id":1038007,"date":"2020-09-21T14:56:39","date_gmt":"2020-09-21T18:56:39","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/is-axsome-therapeutics-inc-axsm-the-top-pick-in-the-biotechnology-industry-investorsobserver\/"},"modified":"2024-08-17T16:13:01","modified_gmt":"2024-08-17T20:13:01","slug":"is-axsome-therapeutics-inc-axsm-the-top-pick-in-the-biotechnology-industry-investorsobserver","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-axsome-therapeutics-inc-axsm-the-top-pick-in-the-biotechnology-industry-investorsobserver.php","title":{"rendered":"Is Axsome Therapeutics Inc (AXSM) the Top Pick in the Biotechnology Industry? &#8211; InvestorsObserver"},"content":{"rendered":"<p><p>A rating of 78 puts Axsome Therapeutics Inc (AXSM) near the top of the Biotechnology industry according to InvestorsObserver. Axsome Therapeutics Inc's score of 78 means it scores higher than 78% of stocks in the industry. Axsome Therapeutics Inc also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 23 out of the 148 industries.<\/p>\n<p>Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks.<\/p>\n<p>These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.<\/p>\n<p>Axsome Therapeutics Inc (AXSM) stock is trading at $77.45 as of  2:13 PM on Monday, Sep 21, a loss of -$4.20, or -5.14% from the previous closing price of $81.65. The stock has traded between  $77.23 and $83.27 so far today. Volume today is 375,402 compared to average volume of 430,624. <\/p>\n<p>Click Here to get the full Stock Score Report on Axsome Therapeutics Inc (AXSM) Stock.<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.investorsobserver.com\/news\/stock-update\/is-axsome-therapeutics-inc-axsm-the-top-pick-in-the-biotechnology-industry-2\" title=\"Is Axsome Therapeutics Inc (AXSM) the Top Pick in the Biotechnology Industry? - InvestorsObserver\" rel=\"noopener noreferrer\">Is Axsome Therapeutics Inc (AXSM) the Top Pick in the Biotechnology Industry? - InvestorsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A rating of 78 puts Axsome Therapeutics Inc (AXSM) near the top of the Biotechnology industry according to InvestorsObserver. Axsome Therapeutics Inc's score of 78 means it scores higher than 78% of stocks in the industry <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-axsome-therapeutics-inc-axsm-the-top-pick-in-the-biotechnology-industry-investorsobserver.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1038007","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038007"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038007"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038007\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}